Novolog 100 unit/ML flexpen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF1U6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,743
Award facts
- Contract value 100% obligated
- $15,742.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $15,742.95 with a completion date of January 28, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across Department of Defense and Veterans Affairs healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to efficiently fulfill government requirements for specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The NovoLog insulin delivery represents a routine pharmaceutical supply requirement supporting military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FF1U6?
SPE2DR26FF1U6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FF1U6 worth?
The government has obligated $15,743 on SPE2DR26FF1U6.
Is contract SPE2DR26FF1U6 an order under another contract?
Yes. SPE2DR26FF1U6 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF1U6 competed?
The extent of competition for SPE2DR26FF1U6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award